PDCD1 and neoplasm: Moreover, in a tumor model, although tumor vaccines increased antigen-specific TILs, they did not decrease PD-1 expression, which impaired the effector function of TILs, nor did they decrease the percentage of MDSCs in the tumor lesions (which accumulated since early-stage and accentuated after immunization) (19).